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Solid silver mercury amalgam electrodes (AgSAEs) represent a suitable alternative to mercury electrodes
due to their similar electrochemical properties and non-toxicity of the amalgam material. Based on this
knowledge, we report the use of silver solid amalgam as working electrode to determine cefepime in
human milk sample. Square-wave voltammogram registered for cefepime in Britton–Robinson buffer
at pH 2.5, presented two well-deﬁned reduction peaks, at 0.28 V (peak 1C) and 0.45 V (peak 2C).
Under optimized condition, the calibration curves presented linear response from 3.0  107 to
2.1  106 mol L1 with limits of detection and quantiﬁcation of 8.51  109 and 2.84  108 mol L1,
respectively. The applicability of the method was veriﬁed using spiked human milk samples and testing
recovery percentages, which were ranged from 98.00% to 100.5%. The obtained results were also com-
pared with those provided with the HPLC technique.
 2012 Elsevier B.V. All rights reserved.1. Introduction
According Vyskocil and Barek, in a review paper [1], during the
1950s and1960s, DCpolarography (DCP)wasoneof theﬁvemost fre-
quently used analytical techniques. However, with the progress of
spectrometric and separation techniques – employed in the determi-
nation of a variety of organic compounds – DCP lost its importance.
Resurgence of eletroanalytical techniqueswasbasedonnewpossibil-
ities in trace analysis from use of square-wave voltammetry (SWV)
and differential pulse voltammetry (DPV) at hanging mercury drop
electrode (HMDE) [1]. However, the toxicity of mercury limits the
usage of the mercury electrodes in the analytical practice and ex-
cludes them from the out-of-laboratory applications [2].
The search for new simple electrochemical sensors for analysis
and study of biomolecules represents an inseparable part of the
development of bioelectrochemical methods and instrumentation.
Recently, new types of metal solid amalgam electrodes (MeSAEs)
for common voltammetric applications were suggested [3–6].
Silver solid amalgam electrodes (AgSAEs), introduced by Mikkelsen
and Schroder and independently by Yosypchuk and Novotny, rep-
resent an intermediate between the mercury electrode and usual
solid electrodes; it combines advantages of both [7]. In this con-
text, the p-MeSAE is closely connected to electrodes based onll rights reserved.
ax: +55 67 3410 2072.
dade), Valdir.ferreira@ufms.bramalgamated metals (Ag, Au, Pt, Ir, Cu). MeSAE can be easily pol-
ished using emery paper followed by wet alumina. They contain
a relatively high content of metal (in the case of AgSAE it is 20%
of Ag or even more) and they can be easily prepared by thorough
mixing of corresponding aliquots of mercury and metal powder
[8]. In this contribution, we show the scope and limitations of
AgSAE on the example of voltammetric determination of cefepime
antibiotic that belongs to the family of cephalosporins.
Cephalosporins are among the safest and the most effective
broad-spectrum bactericidal antimicrobial agents and therefore,
they are the most frequently prescribed class of antibiotics [9].
These are classiﬁed into four generations [10,11] based on their
resistance towards b-lactamase degradation.
Cefepime, [2-aminothiazol-4-yl]-2(Z)-[methoxy-iminoacetami-
do]-3-[methyl-1-pyrrolidino] methyl-ceph3-em4-carboxylic acid
is a new injectable fourth-generation b-lactam cephalosporin with
a positively charged quaternised Nmethyl-pyrrolidine substitution
at the 3 position of the cephem nucleus [12]. The drug is consid-
ered a broad spectrum and shows an excellent activity against
Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa,
Enterobacter cloacae, Staphylococcus aureus and Estreptococos spp.
[13], reaching a wide distribution into most body tissues and ﬂuids
and is excreted in human milk and urine [14,15], which at least
85% is excreted unchanged in human urine. This drug is mainly
used for the treatment of lower respiratory infections, febrile neu-
tropenic events, urinary tract infections skin soft tissue infections,
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and sepsis; it also can be used for children with bacterial meningi-
tis [16,17]. It was reported that both in elective and non-elective
situations, use of prophylactic antibiotics prior to caesarean section
signiﬁcantly reduced the incidence of postpartum infectious mor-
bidities [18]. Used above the therapeutic levels, these drugs can
cause a wide variety of adverse effects and their fast analysis could
have a signiﬁcant impact in treatment and recovery of the patients.
Currently, several analytical methods for the quantitation of cefe-
pimehave been reported due to extensive use of drug inmedical rou-
tine. The analytical methods most often used to determine of
cefepime in biological materials from human origin are liquid chro-
matographywith on-linemicrodialysis [19], high performance liquid
chromatography [20] and spectrophotometry [21]. These methods
give satisfactory sensitivity and selectivity but are rather time con-
suming and have complicated analysis and sample preparation steps.
There is a need for fast, straightforward methods for analysis of
antibiotics and other residuals in human milk, and electroanalyti-
cal techniques have great potential to meet this demand, yielding
results in a matter of minutes without the need for preliminary
sample treatment and ensuring sensitivity comparable to HPLC
methods. In our group, several papers have been published using
the electroanalytical technique for the quantitative determination
of organic compounds in different matrices, such as, milk [22,23]
and bovine serum [24].
Surveying the literature revealed that there are two electro-
chemical methods for determination of cefepime, both related to
Palacios and coworkers [25,26]. This literature is related to the
adsorptive stripping voltammetric determination of cefepime at
the mercury electrode in human urine and cerebrospinal ﬂuid,
and differential pulse polarographic determination in serum.
However, nothing has been published concerning electrochemical
determination of cefepime at silver solid amalgam electrode in hu-
man milk samples. Thus, the aim of this paper is the development
of a fast and simple electroanalytical method for the direct deter-
mination of cefepime in human milk sample without any tedious
pretreatment steps.2. Experimental
2.1. Equipments
Electrochemical experiments were performed with an lAutolab
TYPE II device (Eco Chemie) controlled by General Purpose Electro-
chemical System (GPES) software (Eco Chemie BV). A three-elec-
trode system was employed, which was composed of a silver
solid amalgam electrodes (AgSAEs) (area: 0.52 mm2), an Ag/AgCl
as reference electrode and a platinum wire as auxiliary electrode.
A ProStar chromatographic system (Varian) equippedwith a Pro-
Star 210 ternary pump and a ProStar 325 UV–Vis detector (Varian,
Melbourne, Australia) was employed. Sample injection was per-
formed through a Rheodyne injector valve (Varian, Cotati, CA, USA)
with a 20-lL sample loop. The chromatographic analysis was per-
formed using an OmniSpher C18 (250 mm 4.6 mm, 5 lm) column
(Varian, USA) maintained at 25 C. Before use, the mobile phase was
degassed and vacuum-ﬁltered through 0.45-lm nylon membranes
(Alltech, Belgium), and then pumped at a ﬂow rate of 1.0 mLmin1.
Detection of analyte was performed at 254 nm.
Deionized water was produced by Milli-Q plus system
(Millipore, USA).2.2. Reagents and solutions
A sample of cefepime was kindly provided by Bristol-Myers-
Squibb., Brazil and was used as received. All other chemicals wereof suprapur or analytical reagent grade. Stock solutions of cefepime
(1.0  103 mol Ll) were prepared daily by dissolution of the solid
substance in deionized water. The supporting electrolyte used was
Britton–Robinson (BR) buffer solution, prepared by mixing a solu-
tion 0.04 mol L1 in orthophosphoric acid, 0.04 mol Ll in acetic
acid and 0.04 mol Ll in boric acid with appropriate volumes of
0.2 mol Ll sodium hydroxide. Milk was obtained from healthy
volunteers and kept at 50 C in sterile containers.
Mobile phase used was composed of two solvents: (A) aqueous
solution of dibasic potassium hydrogen phosphate (10 mmol Ll)
at pH 7.0 adjusted with concentrated phosphoric acid and (B)
methanol.
2.3. Preparation and activation of the electrode
The amalgamation was carried out after adjustment of the
process previously published in the literature [8]. The silver solid
amalgam electrodes (AgSAEs) were prepared by packaging silver
powder in a thin glass capillary of internal diameter of about
0.5–1 cm. The electrical contact was made through a platinumwire
(u 0.1 mm) inserted into the silver powder (particle size: 150 nm,
purity: 99.9%, Sigma–Aldrich). The metal powder was then amal-
gamated by liquid mercury. Subsequently, the disc amalgamated
resulting solid was polished manually with aqueous slurry of alu-
mina powder (diameter of 0.01 mm). The surface was electro-
chemically activated in 0.2 mol Ll of KCl supporting solution by
applying a potential of 2.2 V, while the solution was stirred.
The AgSAE performance was tested registering voltammograms
in the BR 0.04 mol L1 before and after addition the target analyte.
For the AgSAE surface regeneration, was applied a potential of
2.2 V during 30 s while the electrolyte solution was stirred. The
electrochemical activation was repeated after the amalgamation,
before starting the work – or after pause longer than hours – or
when occurs lose of electrode performance. This process removed
possible oxides and/or reactants or products adsorbed on the elec-
trode surface. Additionally, the charge transfer resistance became
smaller and more suitable for analytical purposes [27].
2.4. Voltammetric procedure
Ten milliliter of the BR buffer solution was deoxygenated in the
cell with nitrogen gas. After that, an aliquot of standard-electroac-
tive-species solution (30 lL) was added to the electrochemical cell
and the voltammograms were recorded. The experimental and
voltammetric parameters were studied following a systematic
analysis that affect the response, such as the pH of the buffer solu-
tion, the frequency (f) related to the total pulse duration, the pulse
amplitude (a) and the step potential or scan increment (DEs). These
parameters were optimized in relation to the maximum value of
the peak current and the voltammetric resolution (half-peak
width), which enhanced analytical applicability. All measurements
were performed in triplicate and average was used to plot the cal-
ibration curve.
2.5. Chromatographic conditions
The chromatographic condition for the cefepime detection in
human milk was performed after a simple adjustment of the previ-
ous work reported by Farthing and coworkers [28]. Thus, the HPLC
system was used in a gradient elution mode with reversed-phase
column OmniSpher C18 (250 mm  4.6 mm, 5 lm, Varian, USA).
The injection volume was 20 lL and the mobile phase ﬂow rate
was set at 1.0 mL min1.
The mobile phase gradient proﬁle was performed using, respec-
tively, water (containing 10 mmol Ll of K2HPO4) and methanol
according to the following proportions, 80:20 (v/v) between 0
A.M.J. Barbosa et al. / Journal of Electroanalytical Chemistry 681 (2012) 127–132 129and 3 min; decreasing to the 10:90 (v/v) and held for 2 min and
reestablishing the initial condition (80:20, v/v) at 7 min. The mo-
bile phase was degassed using an ultrasound system for 20 min.
Milk human samples were prepared by pipetting 150 lL of milk
and 150 lL of acetonitrile into a polypropylene bullet centrifuge
tube. Milk proteins were precipitated by vortexing for 1.0 min
using a centrifuge (Fanen, Excelsa, 280R, BRA). The vortexed sam-
ples were centrifuged (at 10,000 g) for 10 min at room tempera-
ture. The clear supernatant was transferred to syringe HPLC
(Hamilton, Milford MA, USA) and injected into a loop of 20 lL for
analysis.Fig. 2. Inﬂuence of pH on the peak current (A) and peak potential (B) for the
reduction of cefepime, 5.0  106 mol L1, in BR buffer after 20 s of accumulation
time at 0.15 V. Other conditions as in Fig. 1.2.6. Analysis of spiked milk samples
Milk samples of healthy individuals (after having obtained their
written consent) were stored in refrigerator (50 C). After gentle,
thawing, an aliquot volumeofmilk samplewas spikedwith cefepime
– in concentration range between 3.06  106 and 6.06
106 mol L1 – and left stirred for 5.0 min. These serial dilutions
(samples were mixed with buffer solution at a ratio of about 1:10)
were analyzed in the voltammetric cell containing BR buffer
0.04 mol L1 (pH 2.5) as supporting electrolyte.3. Results and discussion
3.1. Voltammetric studies of cefepime
Fig. 1 shows representative square-wave voltammograms for
electrochemical reduction of 1.0  105 mol L1 of the cefepime
on the AgSAE in BR buffer pH 2.5. The voltammetric response,
towards the negative sweep direction, is characterized to the pres-
ence of two well-deﬁned peaks in BR buffer medium. The ﬁrst one
at peak potential (Ep) = 0.28 V (peak 1C) and the second at around
Ep = 0.45 V (peak 2C) vs. Ag/AgCl (KCl 3.0 mol L1). This response
is similar to that seen in previous works published using mercury
electrode [25], but the reduction waves (peaks 1C and 2C) were
displaced towards positive potentials (200 mV and 450 mV,
respectively) when used the AgSAE. The less cathodic wave (peak
1C) is due to the reduction of the methoxymine group to methanol
and the aminic cephalosporin derivative involving a complex pro-
cess [29]. For analytical interest, we focused our study mainly on
the reduction peak (named peak 2C).Fig. 1. Square-wave voltammograms for reduction of cefepime, 1.0  105 mol L1,
in BR buffer 0.04 mol L1 (pH 2.5) on the AgSAE. Parameter: accumulation potential
(Eacc) = 0.15 V, accumulation time (tacc) = 20 s, frequency (f ) = 60 Hz, scan incre-
ment (DEs) = 5.0 mV and pulse amplitude (a) = 30 mV.The nature and acidity of the supporting buffer are some of the
most important factors which strongly inﬂuence the stability of the
analyte and its cathodic reduction as well as the adsorption pro-
cesses [30]. Among the various investigated buffers (Britton–Rob-
inson, acetate and phosphate) the best voltammetric signal in
terms of sensitivity (peak height) and resolution (peak shape) have
been available using Britton–Robinson buffer.
The dependence of the pH on the peak current (ip) for the buffer
solution is shown in Fig. 2 (curve A). An increase in the peak cur-
rent ip (peak 2C) can be observed for pH values from 2.0 and 5.0,
whereas the peak practically disappears at pH values greater than
5.0. This behavior conﬁrms the presence of chemical reactions
involving protons in the reduction process [31]. Since the pH is a
variable that tends to strongly inﬂuence the shape of voltammo-
grams, the best results with respect to enhancement, shape, and
repeatability of the peak current were obtained with Britton–Rob-
inson buffer (0.04 mol L1) at pH 2.5, thus constituting the most
convenient pH value for further analytical purposes.
At the same time, the inﬂuence of pH on peak potential (Ep) can
be seen in Fig. 2 (curve B). The shape and the position of the peak
current were strongly pH dependent. The peak potential (peak 2C)
is shifted to more negative values with increasing pH, indicating
that protonation of the reactive part of the molecule is involved
in the overall electrode reaction mechanism [32]. The Ep exhibited
also a linear relation with pH, which is expressed by the following
equations: Ep (V) = 0.25–0.089  pH (r = 0.997) for 2.0 6 pH 6 3.0
and Ep (V) = 0.25–0.077 pH (r = 0.995) for 3.5 6 pH 6 5.0, indicat-
ing cefepime reduction involves a protonated form in the investi-
gated pH range.
The dependence of the peak current (peak 2C) on the accumu-
lation potential (Eacc) was evaluated over the range of 0.45 to
0 V vs. Ag/AgCl for electrochemical detection of 5.0  106 mol L1
cefepime at accumulation time of 20 s (Fig. 3). The voltammetric
response was highly inﬂuenced by the accumulation potential.
The peak intensity was maximal when the accumulation potential
was set between 0 and 0.15 V, reaching a maximum value at
0.05 V. At more negative values, a decrease in peak current was
observed, indicating that the drug is no longer adsorbed on the
AgSAE electrode. Therefore, the optimal accumulation potential
was ﬁxed at 0.05 V vs. Ag/AgCl for all further experimental
measurements.
The effect of accumulation time (from 0 to 120 s) on peak
current intensity (Fig. 4) was investigated using square-wave
Fig. 3. Effect of accumulation potential (Eacc) and accumulation time (tacc) on peak
current for the reduction of cefepime, 5.0  106 mol L1, in BR buffer (pH 2.5).
Parameters: (A) tacc = 20 s, f = 60 Hz, DEs = 5.0 mV and a = 30 mV, (B) Eacc = 0.05 V,
f = 60 Hz, DEs = 5.0 mV and a = 50 mV.
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6 mol L1 of cefepime. The peak current intensity decreased notice-
ably when increasing the accumulation time, indicating that long
accumulation times are not favorable for the reduction process of
cefepime on the electrode surface amalgam. Accumulation time
shorter than 20 s—i.e. shorter than the time required for full satu-
ration of the AgSAE electrode surface—was selected to evaluate the
best working condition for the proposed methodology.
The detection of cefepime (5.0  106 mol L1) in BR buffer
(pH 2.5) following preconcentration at Eacc = 0.05 V during 20 s
was optimized after changing the pulse-amplitude (a), scan incre-
ment (DEs) and frequency (f) within the range 10–100 mV,
2.0–16 mV and 10–150 Hz, respectively. The peak current in-
creased with the increase of pulse-amplitude; however a 50 mV
value was chosen since at higher values there was peak distortion.
At a constant pulse-amplitude (a) of 50 mV and a frequency of
60 Hz, the peak current intensity increased linearly over the range
of 2.0 and 12 mV for scan increment (DEs) study. Although current
values rose linearly in this scan increment range, peak distortion
was observed beyond 8.0 mV, resulting in poor deﬁnition of theFig. 4. Square-wave voltammograms obtained for the reduction of cefepime on the
AgSAE for: (a) BR buffer 0.04 mol L1 at pH 2.5, (b) human spiked milk sample
containing 3.0  107 mol L1 of cefepime, (c) 6.0  107 mol L1, (d)
8.0  107 mol L1, (e) 10  107 mol L1, (f) 12  107 mol L1 and (g)
14  107 mol L1 of cefepime. Parameters: f = 60 Hz, a = 50 mV, DEs = 5.0 mV,
tacc = 20 s and Eacc = 0.05 V.peak current shape. Accordingly, a scan increment of 5.0 mV was
preferable in the current study.
A variation in the frequency of application of pulse potential (f)
usually exerts a marked effect on the response of SWV. Based on
this aspect, the effects of frequency on the reduction process of
cefepime on the AgSAE were evaluated for values from 10 to
150 Hz. We observed that an increase in the f values was accompa-
nied by an increase in the peak current (peak 2C). Additionally, no
linear relationship was observed between the peak current and the
frequency. Moreover, the peak potential (Ep) shifted to a more po-
sitive value (around 25 mV) with the increase in frequency. There-
fore, 60 Hz was chosen as an optimal.
Several instrumental parameters, speciﬁcally those that directly
affect the voltammetric response, were optimized for stirring rate
and rest period. The peak current was signiﬁcantly affected when
varying the rest period because it was found that 25 s was sufﬁcient
for the formation of a uniform concentration of the reactant onto
the AgSAE. Thus, a Britton–Robinson buffer (pH 2.5), preconcentra-
tion time (tacc) = 20 s, accumulation potential (Eacc) = 0.05 V, fre-
quency (f) = 60 Hz, scan increment (DEs) = 5.0 mV, and pulse
amplitude (a) = 50 mV were used throughout the development of
electroanalytical method.
3.2. Analytical curves
Calibration curves were constructed using the average peak cur-
rents obtained from recorded voltammograms at cefepime concen-
trations between 3.0  107 and 2.1  106 mol L–1. The peak
current increased linearly over the entire concentration range
investigated (data not showed), according to the equation: ip
(lA) = 1.90 + 4.82  106  C (mol L1), with r = 0.997 (n = 7). The
limits of detection (LOD) and quantiﬁcation (LOQ) were calculated
using the statistic treatment 3  SD/b and 10  SD/b, respectively,
where SD is the standard deviation of then measurement peak cur-
rent for the blank (measured at the potential of cefepime) and m
the slope of the analytical curve [33]. LOD and LOQ were
8.50  109 and 2.80  108 mol L1, respectively.
The satisfactory detectability of adsorptive voltammetry was
accompanied by suitable repeatability. Evaluation of this analytical
performance was based on 10 repeated measurements of the elec-
trochemical signals of cefepime in a 6.0  10–7 mol L–1 pure solu-
tion and in the presence of milk. The precisions of the relative
standard deviation were 0.83% and 2.80%, respectively.
3.3. Determination of cefepime in spiked milk samples
Drugs identiﬁcation was performed according to peaks poten-
tial by comparison with standard solutions and using the standard
addition method. Milk components differ across species, but can
contain signiﬁcant amounts of saturated casein, lipids, carbohy-
drate, and calcium, as well as vitamin C, all of which may interfere
with the electrochemical detection of cefepime. In order to avoid a
matrix effect, the standard addition method was applied, allowing
cefepime to be determined in human milk samples without previ-
ous extraction. Blank sample of milk was spiked with cefepime to
concentrations of 3.06  107 and 6.06  107 mol L1. The spiked
sample was submitted to the procedures described in Section 2.6
and the concentration of the cefepime was measured (Table 1).
Fig. 4 shows representative voltammograms for the milk sample
spiked to a ﬁnal concentration of cefepime (3.06  10–7 mol L–1)
upon successive additions of the standard compound. According
to Fig. 4, there are no reduction peaks of compounds present in
milk sample where the analytical peak appears (peak 2C). Conse-
quently, the voltammetric signal increases after additions of stan-
dard solution, as shown in Fig. 4 (lines b–g), revealing an absence
of matrix effects.
Table 1
Results of recovery assay to accuracy and precision for added cefepime in human milk samples using proposed method and HPLC as reference method.
Analysis method Added (mol L1) Founda (mol L1) Recovery (%) RSD (%) tb Fc
Electroanalytical method 3.06  107 3.00  107 98.00 2.93 1.62 6.37
6.06  107 6.09  107 100.5 3.76 0.28 0.94
HPLC method 3.03  107 2.80  107 92.40 5.94
6.07  107 5.90  107 97.20 0.13
a Average four determinations; RSD: relative standard deviation.
b Conﬁdence level of 95% (tcritical = 3.18).
c Conﬁdence level of 95% (Fcritical = 9.28).
Fig. 5. Chromatograms obtained for: (A) spiked human milk sample containing 3.03  107 mol L1 of cefepime and (B) 3.03  107 mol L1 of cefepime in absence of matrix.
Conditions as described in experimental section.
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replicate measurements on two levels of concentrations
3.06  107 and 6.06  107 mol L1 was found as 98.00% and
100.5%, respectively (Table 1).These results demonstrate that the
proposed method can be successfully employed for cefepime
determination in human milk in a fast, simple manner, without
any sample pretreatment.
3.4. Analysis of human milk sample using HPLC method
To achieve the chromatographic studies human milk samples
were spiked at levels of 3.03  107 and 6.07  107 mol L1 with
cefepime antibiotic. Such samples were then used for veriﬁcation
of the proposed electroanalytical method. A small difference was
found between the mean recoveries involving the electroanalytical
and the chromatographic methods. The average recovery was
92.40% and 97.20%, indicating that the extraction of the analyte
in the chromatographic method may have contributed to the
somewhat lower values in recoveries when compared with the
proposed method (Table 1). Fig. 5 illustrates the chromatographic
proﬁles obtained for spiked milk sample containing
3.03  107 mol L1 of cefepime (Fig. 5, chromatogram A) and
3.03  107 mol L1 of cefepime in absence of matrix (Fig. 5, chro-
matogram B). Thus, the HPLC method was satisfactorily for the
determination of cefepime in human milk samples.
The obtained results, between both methods, were compared
using the Student’s t test and F test. The results summarized in
Table 1 reveal that the experimental values did not exceed the the-
oretical values, since the results were close to the labeled value,
demonstrating that the proposed method is an acceptable alterna-
tive for analytical determination of cefepime in target sample.4. Conclusions
The electrochemical reduction of cefepime onto AgSAE was
studied using square-wave adsorptive cathodic stripping voltam-
metry in a fast and simple procedure. The methodology was ap-
plied for assay of human milk without sample pretreatment or
time-consuming extraction steps prior to analysis of the drug.
The comparison between the analytical data obtained for the
determination of cefepime antibiotic using electroanalytical meth-
od and HPLC/UV–Vis led to very coherent results, indicating that
the proposed electroanalytical method is an important tool to
detect cefepime in small concentrations. Since all procedures were
performed without the use of any organic solvents or hazardous
chemicals which were detrimental to the environment and had a
low consumption of reagents.
Finally, this work demonstrated that the AgSAE can be consid-
ered an environmentally friendly tool and a interesting alternative
for the analytical determination of cefepime in human milk sam-
ple. In addition, the use of the standard addition method allowed
high sample dilution, minimizing matrix effects.Acknowledgements
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